Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CerebraMed

PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Operator of a pharmaceutical company for the treatment of Alzheimer's disease. The company offers a medicinal treatment for patients with Alzheimer's disease to slow down or halt the damage to the brain's nerve cells. The company has developed proprietary GSK-3 inhibitors as drug candidates.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Drug Delivery
Primary Office
  • Tel Aviv
  • Israel
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CerebraMed’s full profile, request a free trial.

CerebraMed Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 03-Feb-2016 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

CerebraMed Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Brainnovations Accelerator/Incubator 000 0000 000000 0

CerebraMed Executive Team (1)

Name Title Board
Seat
Contact
Info
Hagit Eldar-Finkelman Founder